These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7567215)

  • 1. A cotton rat model of effectors of immunity to respiratory syncytial virus other than serum antibody.
    Piazza FM; Schmidt HJ; Johnson SA; Dotson DL; Darnell ME; Ottolini MG; Porter DD; Prince GA
    Pediatr Pulmonol; 1995 Jun; 19(6):355-9. PubMed ID: 7567215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral nasal infection of cotton rats with respiratory syncytial virus allows assessment of local and systemic immunity.
    Johnson SA; Ottolini MG; Darnell ME; Porter DD; Prince GA
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():101-8. PubMed ID: 8558116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection.
    Boukhvalova MS; Blanco JC
    Curr Top Microbiol Immunol; 2013; 372():347-58. PubMed ID: 24362698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
    Piedra PA; Wyde PR; Castleman WL; Ambrose MW; Jewell AM; Speelman DJ; Hildreth SW
    Vaccine; 1993 Nov; 11(14):1415-23. PubMed ID: 7508665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.
    Schneider-Ohrum K; Cayatte C; Bennett AS; Rajani GM; McTamney P; Nacel K; Hostetler L; Cheng L; Ren K; O'Day T; Prince GA; McCarthy MP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection.
    Piazza FM; Johnson SA; Darnell ME; Porter DD; Hemming VG; Prince GA
    J Virol; 1993 Mar; 67(3):1503-10. PubMed ID: 8437227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats.
    Sami IR; Piazza FM; Johnson SA; Darnell ME; Ottolini MG; Hemming VG; Prince GA
    J Infect Dis; 1995 Feb; 171(2):440-3. PubMed ID: 7844385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.
    Kamphuis T; Shafique M; Meijerhof T; Stegmann T; Wilschut J; de Haan A
    Vaccine; 2013 Apr; 31(17):2169-76. PubMed ID: 23499594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats.
    Hwang HS; Kim KH; Lee Y; Lee YT; Ko EJ; Park S; Lee JS; Lee BC; Kwon YM; Moore ML; Kang SM
    Hum Vaccin Immunother; 2017 May; 13(5):1031-1039. PubMed ID: 28129031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.
    O'Konek JJ; Makidon PE; Landers JJ; Cao Z; Malinczak CA; Pannu J; Sun J; Bitko V; Ciotti S; Hamouda T; Wojcinski ZW; Lukacs NW; Fattom A; Baker JR
    Hum Vaccin Immunother; 2015; 11(12):2904-12. PubMed ID: 26307915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    Green G; Johnson SM; Costello H; Brakel K; Harder O; Oomens AG; Peeples ME; Moulton HM; Niewiesk S
    J Virol; 2021 Jul; 95(16):e0001021. PubMed ID: 34037420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
    Wasserman RL; Greener BN; Mond J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1107-1119. PubMed ID: 29035131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.
    Zhan X; Slobod KS; Jones BG; Sealy RE; Takimoto T; Boyd K; Surman S; Russell CJ; Portner A; Hurwitz JL
    Int Immunol; 2015 May; 27(5):229-36. PubMed ID: 25477211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.